118 related articles for article (PubMed ID: 1939466)
1. Determination of urinary vanillactic acid and plasma dihydroxyphenylalanine as markers of non-secreting neuroblastoma by high-performance liquid chromatography with electrochemical detection.
Jouve J; Bakri D; Herault J; Muh JP
J Chromatogr; 1991 Jul; 567(2):331-41. PubMed ID: 1939466
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of plasma 3,4-dihydroxyphenylacetic acid (DOPAC) and plasma 3,4-dihydroxyphenylalanine (DOPA) as tumor markers in children with neuroblastoma.
Eldrup E; Clausen N; Scherling B; Schmiegelow K
Scand J Clin Lab Invest; 2001; 61(6):479-90. PubMed ID: 11681538
[TBL] [Abstract][Full Text] [Related]
3. Clinical validation of urine 3-methoxytyramine as a biomarker of neuroblastoma and comparison with other catecholamine-related biomarkers.
Lam L; Woollard GA; Teague L; Davidson JS
Ann Clin Biochem; 2017 Mar; 54(2):264-272. PubMed ID: 27235704
[TBL] [Abstract][Full Text] [Related]
4. Determination of vanillylmandelic acid, vanillactic acid, and homovanillic acid in dried urine on filter-paper discs by high-performance liquid chromatography with coulometric electrochemical detection for neuroblastoma screening.
Kinoshita Y; Yamada S; Haraguchi K; Takayanagi T; Mori Y; Takahashi T; Haruki E
Clin Chem; 1988 Nov; 34(11):2228-30. PubMed ID: 3180413
[TBL] [Abstract][Full Text] [Related]
5. Simultaneous determination of vanillylmandelic acid, homovanillic acid and creatinine in urine by reversed-phase ion-pair chromatography.
Tokuda T; Tokieda T; Anazawa A; Yoshioka M
J Chromatogr; 1990 Sep; 530(2):418-23. PubMed ID: 2079515
[No Abstract] [Full Text] [Related]
6. Method of measurement of urinary homovanillic acid and vanillylmandelic acid by gas chromatography-mass spectrometry suitable for neuroblastoma screening.
Seviour JA; McGill AC; Dale G; Craft AW
J Chromatogr; 1988 Nov; 432():273-7. PubMed ID: 3220894
[No Abstract] [Full Text] [Related]
7. 3,4-dihydroxyphenylalanine (DOPA) decarboxylase deficiency and resultant high levels of plasma DOPA and dopamine in unfavorable neuroblastoma.
Ikeda H; Matsuyama S; Suzuki N; Takahashi A; Kuroiwa M
Hypertens Res; 1995 Jun; 18 Suppl 1():S209-10. PubMed ID: 8529065
[TBL] [Abstract][Full Text] [Related]
8. Conjugated versus "free" acidic metabolites of catecholamines in random urine samples: significance for the diagnosis of neuroblastoma.
Tuchman M; Stoeckeler JS
Pediatr Res; 1988 Jun; 23(6):576-9. PubMed ID: 3393388
[TBL] [Abstract][Full Text] [Related]
9. Determination by high-performance liquid chromatography with electrochemical detection of free and conjugated N-acetyldopamine excretion in urine of children with neuroblastoma and nephroblastoma.
Jouve J; Herault J; Tournade H; Muh JP
J Chromatogr; 1992 Feb; 574(1):9-15. PubMed ID: 1321164
[TBL] [Abstract][Full Text] [Related]
10. [Clinical significance of 3,4-dihydroxyphenylalanine analysis in endocrine tests of the adrenal medulla and sympathetic nervous system].
Shigetomi S
Nihon Rinsho; 1989 Dec; 48 Suppl():1165-7. PubMed ID: 2516146
[No Abstract] [Full Text] [Related]
11. Cystathioninuria in patients with neuroblastoma.
Rajnherc JR; van Gennip AH; Abeling NG; van der Zee JM; Voûte PA
Med Pediatr Oncol; 1984; 12(2):81-4. PubMed ID: 6422219
[TBL] [Abstract][Full Text] [Related]
12. Analytical validation and clinical application of urinary vanillylmandelic acid and homovanillic acid by LC-MS/MS for diagnosis of neuroblastoma.
Shen Y; Li H; Lu J; Luo X; Guan Q; Cheng L
Biomed Chromatogr; 2019 Jun; 33(6):e4484. PubMed ID: 30632178
[TBL] [Abstract][Full Text] [Related]
13. Combined measurements of plasma aromatic L-amino acid decarboxylase and DOPA as tumour markers in diagnosis and follow-up of neuroblastoma.
Boomsma F; Ausema L; Hakvoort-Cammel FG; Oosterom R; Man in't Veld AJ; Krenning EP; Hahlen K; Schalekamp MA
Eur J Cancer Clin Oncol; 1989 Jul; 25(7):1045-52. PubMed ID: 2503383
[TBL] [Abstract][Full Text] [Related]
14. Urinary excretion of 3-methoxy-4-hydroxymandelic acid and 3-methoxy-4-hydroxyphenylacetic acid by 288 patients with neuroblastoma and related neural crest tumors.
LaBrosse EH; Com-Nougué C; Zucker JM; Comoy E; Bohuon C; Lemerle J; Schweisguth O
Cancer Res; 1980 Jun; 40(6):1995-2001. PubMed ID: 7371035
[No Abstract] [Full Text] [Related]
15. Determination of 3,4-dihydroxyphenylalanine (DOPA) in plasma and cerebrospinal fluid by high performance liquid chromatography with electrochemical detection.
Boomsma F; van der Hoorn FA; Man in 't Veld AJ; Schalekamp MA
Clin Chim Acta; 1988 Nov; 178(1):59-69. PubMed ID: 3147824
[TBL] [Abstract][Full Text] [Related]
16. Determination of serum catecholamine metabolites in neuroblastoma by high performance liquid chromatography with electrochemical detection.
Tang QM; Xu XR; Shi YQ; Jin BX
Biomed Chromatogr; 1986 Feb; 1(1):7-11. PubMed ID: 3506818
[TBL] [Abstract][Full Text] [Related]
17. Determination of free DOPA and 3-O-methyl-DOPA in human plasma by high-performance liquid chromatography with electrochemical detection.
Melzi d'Eril GV; Rizzo V
J Chromatogr; 1991 Aug; 553(1-2):265-9. PubMed ID: 1787158
[TBL] [Abstract][Full Text] [Related]
18. Plasma dopa and catecholamines in the diagnosis and follow-up of children with neuroblastoma.
Alvarado CS; Faraj BA; Kim TH; Camp VM; Bain RP; Ragab AH
Am J Pediatr Hematol Oncol; 1985; 7(3):221-7. PubMed ID: 3934994
[TBL] [Abstract][Full Text] [Related]
19. Paediatric reference values for urinary catecholamine metabolites evaluated by high performance liquid chromatography and electrochemical detection.
Marchese N; Canini S; Fabi L; Famularo L
Eur J Clin Chem Clin Biochem; 1997 Jul; 35(7):533-7. PubMed ID: 9263730
[TBL] [Abstract][Full Text] [Related]
20. Improved solid-phase extraction and liquid chromatography with electrochemical detection of urinary catecholamines and 5-S-L-cysteinyl-L-dopa.
Huang TH; Wall J; Kabra P
J Chromatogr; 1988 Oct; 452():409-18. PubMed ID: 3149647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
